What this domain asks
Risk that regulated content cannot be planned, authored, approved, assembled, validated, transmitted, received, and maintained in the correct format and lifecycle for the relevant authority and procedure.
The domain should retain its own evidence, decision owner, materiality criteria, exception path, and consequence even when it shares organization identity, workflow, or technology with adjacent domains. Aggregation can support oversight; it should not erase the evidence behind different risks or operating outcomes.
Buyer questions
- Which submission formats, regions, procedures, application types, and implementation-package versions are supported today?
- How are submission plans connected to approved source content, expected documents, product data, activities, and commitments?
- Can the platform distinguish content readiness from technical publishing readiness and authority receipt?
- How are validation criteria, controlled vocabularies, regional module-one changes, and transmission specifications updated and tested?
- What is native, integrated, exported to a specialist publisher, or delivered as a service?
- Can the complete dossier, lifecycle, validation results, acknowledgments, metadata, and source relationships be archived and transferred?
Mapped workflows
Controlled Documents
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for controlled documents within this domain.
Regulatory Product And Registration Data
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for regulatory product and registration data within this domain.
Regulatory Activity And Commitment Tracking
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for regulatory activity and commitment tracking within this domain.
Submission Planning And Dossier Management
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for submission planning and dossier management within this domain.
Submission Publishing And Technical Validation
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for submission publishing and technical validation within this domain.
Health-Authority Correspondence
A demonstration should show the trigger, source, accountable role, decision, exception, evidence, and downstream handoff for health-authority correspondence within this domain.
Authority context
FDA 21 CFR Part 11
Part 11 defines criteria under which FDA considers electronic records, electronic signatures, and handwritten signatures executed to electronic records trustworthy, reliable, and generally equivalent to paper records and handwritten signatures.
EU GMP Chapter 4
Chapter 4 describes expectations for the generation, control, review, approval, distribution, maintenance, and retention of GMP documentation and records, including paper, electronic, photographic, and other media.
eCTD v4.0
eCTD v4.0 defines a harmonised structure and exchange model for regulatory submissions, with regional controlled vocabularies, module-one requirements, validation criteria, transmission specifications, and implementation timelines maintained by authorities.
ISO IDMP
The ISO IDMP family standardizes the identification and description of substances, dose forms and routes, units of measurement, regulated pharmaceutical products, and regulated medicinal products. EMA is implementing these concepts through substance, product, organization, and referential master-data services.
Relevant operating models
- Integrated Quality And Regulatory Platform
- Enterprise Regulatory Information Management Suite
- Regulatory Submissions And Publishing Platform
- Medical-Device Regulatory Information Management
- Regulatory Content And Document Management
Evidence boundary
RegQuality Review is not a regulator, certification body, law firm, or validation authority. Its records support research and decision review; they do not establish compliance for an organization, system, release, configuration, or intended use. A provider's documented capability can identify a research candidate but cannot establish buyer-specific adequacy for this domain.